Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

GALTEN KIROPRAKTISK KLINIK ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.6%   Bankruptcy risk   6.3% 3.8% 3.1% 2.9% 2.4% 2.5% 24.0% 21.1%   Credit score (0-100)   40 53 58 58 62 62 2 5   Credit rating   BBB BBB BBB BBB BBB BBB B B   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   2,196 2,359 2,793 2,894 2,981 2,886 0.0 0.0   EBITDA   118 179 331 444 414 318 0.0 0.0   EBIT   80.3 166 319 435 393 291 0.0 0.0   Pre-tax profit (PTP)   79.5 166.2 317.7 431.4 385.6 285.2 0.0 0.0   Net earnings   61.9 129.6 247.4 336.5 307.9 222.3 0.0 0.0   Pre-tax profit without non-rec. items   79.5 166 318 431 386 285 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Tangible assets total   28.8 23.9 30.5 21.6 206 179 0.0 0.0   Shareholders equity total   252 320 439 535 543 414 0.2 0.2   Interest-bearing liabilities   0.6 0.0 0.0 35.5 79.8 153 0.0 0.0   Balance sheet total (assets)   450 539 709 1,094 970 812 0.2 0.2   Net Debt   -285 -345 -468 -865 -586 -372 -0.2 -0.2     See the entire balance sheet 1000.0 Volume  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   2,196 2,359 2,793 2,894 2,981 2,886 0.0 0.0   Gross profit growth   13.2% 7.4% 18.4% 3.6% 3.0% -3.2% -100.0% 0.0%   Employees   5 5 4 5 5 5 0 0   Employee growth %   25.0% 0.0% -20.0% 25.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   450 539 709 1,094 970 812 0 0   Balance sheet change%   -12.6% 19.7% 31.5% 54.3% -11.3% -16.3% -100.0% 0.0%   Added value   80.3 166.2 318.5 435.3 393.0 290.6 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -65 -18 -6 -18 164 -54 -179 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   3.7% 7.0% 11.4% 15.0% 13.2% 10.1% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   16.7% 33.8% 51.3% 48.3% 38.1% 32.6% 0.0% 0.0%   ROI %   26.8% 58.5% 84.3% 86.3% 65.8% 48.4% 0.0% 0.0%   ROE %   20.6% 45.3% 65.2% 69.1% 57.1% 46.5% 0.0% 0.0%   1000.0 Solidity  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Equity ratio %   55.9% 59.4% 61.9% 48.9% 56.0% 51.0% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -240.5% -192.4% -141.5% -194.7% -141.6% -117.1% 0.0% 0.0%   Gearing %   0.2% 0.0% 0.0% 6.6% 14.7% 36.9% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   445.7% 383.6% 0.0% 22.1% 12.7% 4.6% 0.0% 0.0%   1000.0 Liquidity  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Quick Ratio   1.9 2.2 2.4 1.8 1.7 1.5 0.0 0.0   Current Ratio   1.9 2.2 2.4 1.8 1.7 1.5 0.0 0.0   Cash and cash equivalent   285.1 344.9 468.1 900.4 665.7 525.0 0.0 0.0   1000.0 Capital use efficiency  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   184.8 258.0 369.5 474.9 299.6 205.4 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   16 33 80 87 79 58 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   24 36 83 89 83 64 0 0   EBIT / employee   16 33 80 87 79 58 0 0   Net earnings / employee   12 26 62 67 62 44 0 0